Found: 28
Select item for more details and to access through your institution.
Tofogliflozin does not delay progression of carotid atherosclerosis in patients with type 2 diabetes: a prospective, randomized, open-label, parallel-group comparative study.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. 1, doi. 10.1186/s12933-020-01079-4
- By:
- Publication type:
- Article
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
- Published in:
- Cardiovascular Diabetology, 2023, v. 22, n. 1, p. 1, doi. 10.1186/s12933-023-01879-4
- By:
- Publication type:
- Article
Effect of sodium–glucose cotransporter 2 inhibitors on serum low‐density lipoprotein cholesterol in Japanese patients with type 2 diabetes mellitus.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 7, p. 843, doi. 10.1111/jdi.14179
- By:
- Publication type:
- Article
High prevalence and clinical impact of dynapenia and sarcopenia in Japanese patients with type 1 and type 2 diabetes: Findings from the Impact of Diabetes Mellitus on Dynapenia study.
- Published in:
- Journal of Diabetes Investigation, 2021, v. 12, n. 6, p. 1050, doi. 10.1111/jdi.13436
- By:
- Publication type:
- Article
Impact of diabetes on coronary stenosis and coronary artery calcification detected by electron-beam computed tomography in symptomatic patients.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Associations of continuous glucose monitoring-assessed glucose variability with intima-media thickness and ultrasonic tissue characteristics of the carotid arteries: a cross-sectional analysis in patients with type 2 diabetes.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-021-01288-5
- By:
- Publication type:
- Article
Effect of tofogliflozin on arterial stiffness in patients with type 2 diabetes: prespecified sub-analysis of the prospective, randomized, open-label, parallel-group comparative UTOPIA trial.
- Published in:
- Cardiovascular Diabetology, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12933-020-01206-1
- By:
- Publication type:
- Article
Ptf1a and RBP-J Cooperatively Regulate Pdx1 Gene Expression Through Binding to Conserved Sequences Within Area HI.
- Published in:
- Diabetes, 2007, v. 56, p. A429
- By:
- Publication type:
- Article
The Influence of Tofogliflozin on Treatment-Related Quality of Life in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 9, p. 2499, doi. 10.1007/s13300-021-01125-8
- By:
- Publication type:
- Article
Rationale, Design, and Baseline Characteristics of the Utopia Trial for Preventing Diabetic Atherosclerosis Using an SGLT2 Inhibitor: A Prospective, Randomized, Open-Label, Parallel-Group Comparative Study.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 5, p. 999, doi. 10.1007/s13300-017-0292-1
- By:
- Publication type:
- Article
Rationale, design, and baseline characteristics of a clinical trial for prevention of atherosclerosis in patients with insulin-treated type 2 diabetes mellitus using DPP-4 inhibitor: the Sitagliptin Preventive study of Intima-media thickness Evaluation (SPIKE)
- Published in:
- Diabetology & Metabolic Syndrome, 2014, v. 6, n. 1, p. 1, doi. 10.1186/1758-5996-6-35
- By:
- Publication type:
- Article
A case of ectopic ACTH syndrome due to DDAVP-sensitive but V1b receptor-negative bronchial typical carcinoid with lymphatic metastasis and plasma ProGRP elevation.
- Published in:
- Endocrine Journal, 2018, v. 65, n. 12, p. 1161, doi. 10.1507/endocrj.ej18-0052
- By:
- Publication type:
- Article
Clinical and endocrinological characteristics of adrenal incidentaloma in Osaka region, Japan.
- Published in:
- Endocrine Journal, 2016, v. 63, n. 1, p. 29, doi. 10.1507/endocrj.ej15-0404
- By:
- Publication type:
- Article
Erratum. Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A). Diabetes Care 2016;39:139-148.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Erratum. Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE). A Randomized Controlled Trial. Diabetes Care 2016;39:455-464.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Basal insulin requirement is ~30% of the total daily insulin dose in type 1 diabetic patients who use the insulin pump.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Basal Insulin Requirement Is ~30% of the Total Daily Insulin Dose in Type 1 Diabetic Patients Who Use the Insulin Pump.
- Published in:
- Diabetes Care, 2011, v. 34, n. 5, p. 1089, doi. 10.2337/dc10-2149
- By:
- Publication type:
- Article
Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41036-1
- By:
- Publication type:
- Article
Long-term efficacy and safety of early alogliptin initiation in subjects with type 2 diabetes: an extension of the SPEAD-A study.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-41036-1
- By:
- Publication type:
- Article
The MafA Transcription Factor Becomes Essential to Islet β-Cells Soon After Birth.
- Published in:
- Diabetes, 2014, v. 63, n. 6, p. 1994, doi. 10.2337/db13-1001
- By:
- Publication type:
- Article
Nuclear hormone retinoid X receptor (RXR) negatively regulates the glucose-stimulated insulin secretion of pancreatic ß-cells.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Nuclear Hormone Retinoid X Receptor (RXR) Negatively Regulates the Glucose-Stimulated Insulin Secretion of Pancreatic β-cells.
- Published in:
- Diabetes, 2010, v. 59, n. 11, p. 2854, doi. 10.2337/db09-1897
- By:
- Publication type:
- Article
MafA and MafB regulate genes critical to beta-cells in a unique temporal manner.
- Published in:
- 2010
- By:
- Publication type:
- journal article
MafA and MafB Regulate Genes Critical to β-Cells in a Unique Temporal Manner.
- Published in:
- Diabetes, 2010, v. 59, n. 10, p. 2530, doi. 10.2337/db10-0190
- By:
- Publication type:
- Article
Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Regulation of MafA Expression in Pancreatic βCells in db/db Mice With Diabetes.
- Published in:
- Diabetes, 2010, v. 59, n. 7, p. 1709, doi. 10.2337/db08-0693
- By:
- Publication type:
- Article